We are live on
!
Find out more
RT
Reliance Trust Portfolio holdings
AUM
$27.5M
1-Year Est. Return
6.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+6.41%
3 Year Est. Return
+32.11%
5 Year Est. Return
+40.7%
10 Year Est. Return
–
AUM
$89M
AUM Growth
-$13.2M
(-13%)
Cap. Flow
-$16.8M
Cap. Flow
% of AUM
-18.85%
Top 10 Holdings %
Top 10 Hldgs %
24.12%
Holding
166
New
8
Increased
23
Reduced
98
Closed
22
Avg Time Held
3.5
quarters
Top 10 Avg Time Held
2.3
quarters
Top 20 Avg Time Held
2.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Equity ETF
SCHF
|
+$400K |
| 2 |
Tapestry
TPR
|
+$297K |
| 3 |
eBay
EBAY
|
+$227K |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$204K |
| 5 |
TotalEnergies
TTE
|
+$200K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$2.35M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$935K |
| 3 |
AbbVie
ABBV
|
+$831K |
| 4 |
ExxonMobil
XOM
|
+$763K |
| 5 |
Abbott
ABT
|
+$717K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.53% |
| 2 | Consumer Staples | 13.63% |
| 3 | Financials | 13.18% |
| 4 | Energy | 10.96% |
| 5 | Technology | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
GSK
GSK
$92.7B
| $510K | 0.57% |
7,635
+806
| +12% | +$54.6K |
2013 Q2
4 quarters
|
|
52
Duke Energy
DUK
$92.2B
| $509K | 0.57% |
6,855
-2,393
| -26% | -$172K |
2013 Q2
4 quarters
|
|
53
DELISTED
Du Pont De Nemours E I
DD
| $501K | 0.56% |
8,064
-247
| -3% | -$15.9K |
2013 Q2
4 quarters
|
|
54
Colgate-Palmolive
CL
$71.7B
| $499K | 0.56% |
7,328
-672
| -8% | -$45K |
2013 Q2
4 quarters
|
|
55
Mondelez International
MDLZ
$78.5B
| $488K | 0.55% |
12,972
-2,651
| -17% | -$96.9K |
2013 Q2
4 quarters
|
|
56
Boeing
BA
$147B
| $479K | 0.54% |
3,764
-544
| -13% | -$71K |
2013 Q2
4 quarters
|
|
57
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $477K | 0.54% |
9,042
-758
| -8% | -$40K |
2013 Q2
4 quarters
|
|
58
RTX Corp
RTX
$247B
| $465K | 0.52% |
6,405
-664
| -9% | -$48.9K |
2013 Q2
4 quarters
|
|
59
Berkshire Hathaway Class B
BRK.B
$1.11T
| $463K | 0.52% |
3,662
-600
| -14% | -$75.9K |
2013 Q2
4 quarters
|
|
60
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.67B
| $443K | 0.5% |
4,153
+33
| +0.8% | +$3.53K |
2013 Q2
4 quarters
|
|
61
Bristol-Myers Squibb
BMY
$116B
| $441K | 0.5% |
9,085
-1,904
| -17% | -$93.8K |
2013 Q2
4 quarters
|
|
62
BP
BP
$125B
| $439K | 0.49% |
10,164
-1,186
| -10% | -$48.9K |
2013 Q2
4 quarters
|
|
63
MetLife
MET
$64B
| $437K | 0.49% |
8,841
-1,349
| -13% | -$63.1K |
2013 Q2
4 quarters
|
|
64
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
| $437K | 0.49% |
8,342
-366
| -4% | -$18.7K |
2013 Q2
4 quarters
|
|
65
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
| $428K | 0.48% |
4,915
+155
| +3% | +$13K |
2013 Q2
4 quarters
|
|
66
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.9B
| $418K | 0.47% |
3,277
+204
| +7% | +$24.7K |
2013 Q2
4 quarters
|
|
67
Phillips 66
PSX
$117B
| $415K | 0.47% |
5,158
-161
| -3% | -$13.3K |
2013 Q2
4 quarters
|
|
|
WFM
68
DELISTED
Whole Foods Market Inc
WFM
| $413K | 0.46% |
10,674
+353
| +3% | +$15.4K |
2013 Q2
4 quarters
|
|
69
Enterprise Products Partners
EPD
$77.8B
| $410K | 0.46% |
10,492
| – | – |
2013 Q2
4 quarters
|
|
70
Medtronic
MDT
$119B
| $385K | 0.43% |
6,035
-335
| -5% | -$20.4K |
2013 Q2
4 quarters
|
|
71
Stryker
SYK
$108B
| $385K | 0.43% |
4,566
+31
| +0.7% | +$2.53K |
2013 Q2
4 quarters
|
|
72
State Street SPDR S&P Dividend ETF
SDY
$21B
| $381K | 0.43% |
4,969
| – | – |
2013 Q2
4 quarters
|
|
73
American Express
AXP
$209B
| $377K | 0.42% |
3,983
-126
| -3% | -$11.4K |
2013 Q2
4 quarters
|
|
|
BSJF
74
DELISTED
GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF
BSJF
| $366K | 0.41% |
13,605
| – | – |
2014 Q1
1 quarter
|
|
75
Vanguard Total Bond Market
BND
$162B
| $363K | 0.41% |
4,418
+912
| +26% | +$74.5K |
2013 Q2
4 quarters
|
|
Similar funds
PIA
FCG
RCP
MP
MAU
JRWL
CPA
AGU
Reliance Trust's Q2 2014 Portfolio in Review
As of Q2 2014, Reliance Trust held 166 positions worth $89M, down 13% from $102M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Reliance Trust withdrew a net $16.8M in Q2 2014, closing 22 positions and reducing 98 holdings. Its most notable exit was AT&T, an estimated $2.35M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 20% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Reliance Trust opened a new position in Tapestry worth $237K.
- Reliance Trust's largest Q2 2014 buy was Tapestry: 6,928 shares worth $237K.
- Reliance Trust added most to Schwab International Equity ETF in Q2 2014, an estimated $400K increase.
- Reliance Trust's biggest Q2 2014 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $935K.
- Reliance Trust fully exited AT&T in Q2 2014, selling an estimated $2.35M.
- Reliance Trust's ten largest holdings make up 24% of its $89M portfolio in Q2 2014.
- Reliance Trust opened 8 new positions and closed 22 in Q2 2014.
- Reliance Trust's portfolio value fell 13% quarter-over-quarter to $89M.
Based on Reliance Trust's 13F filing for Q2 2014, filed 11 Jul 2014.